2003 Senate Bill 41

Introduced in the Senate

Jan. 22, 2003

Introduced by Sen. Beverly Hammerstrom (R-17)

To require public disclosure of prescription drug advertising and marketing expenses by private pharmaceutical companies.

Referred to the Committee on Health Policy